Cargando…

WCN23-0709 OUTCOMES AND CLINICAL CHARACTERISTICS OF ESKD PATIENTS WITH COVID-19 IN A PERUVIAN HOSPITAL IN THE TWO FIRST WAVES

Detalles Bibliográficos
Autores principales:	Rodriguez Mori, J., Gutierrez Damián, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2023
Materias:	Covid-19 and KF (Kidney Failure)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025601/ http://dx.doi.org/10.1016/j.ekir.2023.02.1033

Ejemplares similares

WCN23-0144 OUTCOME OF COVID 19 PATIENTS REQUIRING HEMODIALYSIS
por: SAMAD, M., et al.
Publicado: (2023)

WCN23-1156 INCIDENCE RATE OF COVID-19 HEMODIALYSIS UNIT ADMISSION AMONG CONGOLESE PATIENTS: EXPERIENCE DURING THE FIRST 4 WAVES OF THE PANDEMIC
por: Nlandu Mayamba, Y., et al.
Publicado: (2023)

WCN23-0022 SUCCESSFUL KIDNEY TRANSPLANTATION FROM COVID-19 POSITIVE DONORS
por: GAMA, R., et al.
Publicado: (2023)

WCN23-1215 CLINICAL CHARACTERISTICS OF HEMODIALYSIS PATIENTS HOSPITALIZED WITH COVID-19: A CASE SERIES OF 70 CASES FROM DOMINICAN REPUBLIC
por: Atizol Rodriguez, D., et al.
Publicado: (2023)

WCN23-0983 IMPACT OF COVID-19 PANDEMIC ON MANAGEMENT OF PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
por: Saeed, B.
Publicado: (2023)

WCN23-1214 COVID-19 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS: A SINGLE-CENTER CASE SERIES OF 10 CASES FROM DOMINICAN REPUBLIC
por: Atizol Rodriguez, D., et al.
Publicado: (2023)

WCN23-0636 CHALLENGES OF TREATING COVID 19 IN PATIENTS WITH CHRONIC RENAL FAILURE UNDER LIMITED CONDITIONS
por: PILCEVIC, D., et al.
Publicado: (2023)

WCN23-0117 PAXLOVID ( NIRMATRELVIR/RITONAVIR ) AND CYCLOSPORIN IN A KIDNEY TRANSPLANT PATIENT WITH COVID-19 INFECTION
por: Then, R.F., et al.
Publicado: (2023)

WCN23-0583 GROSS HEMATURIA AFTER COVID-19 mRNA VACCINATION: A PROSPECTIVE COHORT STUDY
por: AOKI, R., et al.
Publicado: (2023)

WCN23-0318 IMPACT OF COVID VACCINATION ON HOSPITALIZED COVID-19 PATIENTS - A RENAL AND EXTRA-RENAL OUTCOME STUDY
por: OOI, S., et al.
Publicado: (2023)

WCN23-0592 KIDNEY TRANSPLANTATION DURING THE THREE YEARS (2020-2022) OF COVID-19 PANDEMIC: SINGLE-CENTER EXPERIENCE
por: Komissarov, K., et al.
Publicado: (2023)

WCN23-0190 HIGH SEROCONVERSION RATES AFTER 2 DOSES OF VACCINE AGAINST SARS-COV-2 IN KIDNEY TRANSPLANT RECIPIENTS
por: Bajpai, D., et al.
Publicado: (2023)

WCN23-0034 A COMPARISON OF GAM-COVID-VAC (SPUTNIK V) VACCINE IMMUNOGENICITY IN HEMODIALYSIS PATIENTS AND NON-RENAL SUBJECTS
por: PARSHINA, E., et al.
Publicado: (2023)

WCN23-1051 COVID-19 VACCINATION AND COVID 19 INFECTION IN ATYPICAL HEMOLYTIC UREMIC SYNDROME: ONE SINGLE CENTER STUDY IN TAIWAN
por: CHEN, I.R., et al.
Publicado: (2023)

WCN23-0601 MORTALITY OF PATIENTS WITH CKD AND ITs RISK FACTORS ADMITTED TO HOSPITAL WITH COVID-19 IN ALMATY CITY KAZAKHSTAN BETWEEN 2020-2022
por: GARAZHAYEVA, L., et al.
Publicado: (2023)

WCN23-1235 STATUS OF ANTIBODY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2: PRELIMINARY REPORTS ON SEROPREVALENCE OF COVID 19 IN AMONG HEALTH CARE WORKERS
por: Iqbal, M., et al.
Publicado: (2023)

WCN23-1139 A Study of Long-Term Outcome of Mycophenolate Dose Modulation in Renal Allograft Recipients With SARS-CoV2 Infection During COVID-19 Pandemic
por: MEYYAPPAN, J., et al.
Publicado: (2023)

WCN23-0222 ELEVATED LACTATE DEHYDROGENASE IS ASSOCIATED WITH POOR OUTCOME IN COVID-19 PATIENTS WITH END-STAGE RENAL DISEASE: A RETROSPECTIVE STUDY IN A TERTIARY PUBLIC HOSPITAL IN PHILIPPINES
por: CELENDRO, H.M., et al.
Publicado: (2023)

WCN23-1041 IMMUNOGENICITY AND SAFETY OF HOMOLOGOUS CHADOX1 NCOV-19 AND HETEROLOGOUS PRIME-BOOST OF CORONAVAC AND CHADOX1 NCOV-19 AMONG KIDNEY TRANSPLANT RECIPIENTS: AN OBSERVATIONAL PROSPECTIVE COHORT STUDY
por: Narongkiatikhun, P., et al.
Publicado: (2023)

WCN23-0624 ACUTE KIDNEY INJURY AND COVID-19
por: JERNDAL, H., et al.
Publicado: (2023)

WCN23-1131 RISK OF AKI IN COVID-19 PATIENTS: CLINICAL COURSE AND OUTCOMES
por: Flores Fonseca MD, M.M., et al.
Publicado: (2023)

WCN23-0981 RISK FACTORS FOR COVID-19 MORTALITY IN HEMODIALYSIS PATIENTS
por: TOMANOSKI, V., et al.
Publicado: (2023)

WCN23-0316 COVID-19 VACCINATION INDUCED MINIMAL CHANGED DISEASE
por: ALKANDARI, N., et al.
Publicado: (2023)

WCN23-0430 PREDICTORS FOR FAILURE REDUCTION OF HEMODIALYSIS FREQUENCY DURING THE PANDEMIC
por: Pattharanitima, P., et al.
Publicado: (2023)

WCN23-0345 EFFECTIVENESS OF COVID-19 VACCINE IN PATIENT UNDERGOING HEMODIALYSIS
por: FATIMAH, S., et al.
Publicado: (2023)

WCN23-0333 THE FREQUENCY OF DYSNATREMIA IN PATIENTS ADMITTED WITH COVID-19 INFECTION
por: KHAN, F.G., et al.
Publicado: (2023)

WCN23-1032 CHARACTERISTICS OF ACUTE KIDNEY INJURY IN COVID-19 ADULT PATIENTS IN A SINGLE CENTER IN INDONESIA
por: Muzasti, R., et al.
Publicado: (2023)

WCN23-1216 KIDNEY BIOPSIES DURING THE COVID-19 OUTBREAK: A SERIES OF CASES
por: Pantaleon, H., et al.
Publicado: (2023)

WCN23-0651 LONG-TERM EFFECTIVENESS OF COVID-19 VACCINE AMONG DIALYSIS PATIENTS
por: Rosa Diez, G., et al.
Publicado: (2023)

WCN23-0825 TELENEPHROLOGY: MANAGING CHRONIC KIDNEY DISEASE DURING COVID-19 PANDEMIC
por: Sharma, S.K., et al.
Publicado: (2023)

WCN23-1238 COMORBIDITIES ASSOCIATED WITH INCREASED RISK OF DEATH IN CKD PATIENTS WITH COVID-19
por: BRAZ, B., et al.
Publicado: (2023)

WCN23-0213 PROXIMAL TUBULAR DYSFUNCTION AS A PREDICTOR OF AKI IN HOSPITALIZED COVID-19 PATIENTS
por: ALIMUL BARI, A., et al.
Publicado: (2023)

WCN23-0616 SARS-COV-2 INFECTION AMONG HOSPITALIZED PATIENTS WITH CHRONIC KIDNEY DISEASE
por: Munaa, B., et al.
Publicado: (2023)

WCN23-0071 CYTOKINE ADSORBING COLUMN IN SEVERE COVID-19 PATIENTS WITH ACUTE KIDNEY INJURY
por: Madhyastha, P., et al.
Publicado: (2023)

WCN23-0317 AKI IN HOSPITALIZED COVID-19 PATIENTS- AN EPIDEMIOLOGY STUDY IN A TERTIARY CENTER
por: OOI, S., et al.
Publicado: (2023)

WCN23-0857 Utility of urinary biomarkers for diagnosis of acute kidney injury (AKI) in COVID-19
por: SAMRA, T., et al.
Publicado: (2023)

WCN23-0787 A CASE OF IGA VASCULITIS THAT DEVELOPED GROSS HEMATURIA AND LOWER-LIMB PURPURA FOLLOWING COVID-19 VACCINES
por: MORI, K., et al.
Publicado: (2023)

WCN23-1046 PATHOGENETIC ASPECTS OF THE DEVELOPMENT OF ACUTE KIDNEY INJURY IN COVID 19: OWN OBSERVATION DATA
por: GARAZHAYEVA, L., et al.
Publicado: (2023)

WCN23-0359 RENAL FLARE IN ADOLESCENTS WITH LUPUS NEPHRITIS RECEIVED COVID-19 mRNA VACCINE
por: THEPVEERA, S., et al.
Publicado: (2023)

WCN23-0357 Quercetin potentially suppresses renal fibrosis in patients with COVID-19 under hypoxic state
por: GUO, J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qf62gep3ak5lqisj87u6dikl8o